Cargando…
Can composite digital monitoring biomarkers come of age? A framework for utilization
INTRODUCTION: The application of digital monitoring biomarkers in health, wellness and disease management is reviewed. Harnessing the near limitless capacity of these approaches in the managed healthcare continuum will benefit from a systems-based architecture which presents data quality, quantity,...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5916505/ https://www.ncbi.nlm.nih.gov/pubmed/29707260 http://dx.doi.org/10.1017/cts.2018.4 |
_version_ | 1783317022552096768 |
---|---|
author | Kovalchick, Christopher Sirkar, Rhea Regele, Oliver B. Kourtis, Lampros C. Schiller, Marie Wolpert, Howard Alden, Rhett G. Jones, Graham B. Wright, Justin M. |
author_facet | Kovalchick, Christopher Sirkar, Rhea Regele, Oliver B. Kourtis, Lampros C. Schiller, Marie Wolpert, Howard Alden, Rhett G. Jones, Graham B. Wright, Justin M. |
author_sort | Kovalchick, Christopher |
collection | PubMed |
description | INTRODUCTION: The application of digital monitoring biomarkers in health, wellness and disease management is reviewed. Harnessing the near limitless capacity of these approaches in the managed healthcare continuum will benefit from a systems-based architecture which presents data quality, quantity, and ease of capture within a decision-making dashboard. METHODS: A framework was developed which stratifies key components and advances the concept of contextualized biomarkers. The framework codifies how direct, indirect, composite, and contextualized composite data can drive innovation for the application of digital biomarkers in healthcare. RESULTS: The de novo framework implies consideration of physiological, behavioral, and environmental factors in the context of biomarker capture and analysis. Application in disease and wellness is highlighted, and incorporation in clinical feedback loops and closed-loop systems is illustrated. CONCLUSIONS: The study of contextualized biomarkers has the potential to offer rich and insightful data for clinical decision making. Moreover, advancement of the field will benefit from innovation at the intersection of medicine, engineering, and science. Technological developments in this dynamic field will thus fuel its logical evolution guided by inputs from patients, physicians, healthcare providers, end-payors, actuarists, medical device manufacturers, and drug companies. |
format | Online Article Text |
id | pubmed-5916505 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Cambridge University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-59165052018-04-27 Can composite digital monitoring biomarkers come of age? A framework for utilization Kovalchick, Christopher Sirkar, Rhea Regele, Oliver B. Kourtis, Lampros C. Schiller, Marie Wolpert, Howard Alden, Rhett G. Jones, Graham B. Wright, Justin M. J Clin Transl Sci Research Methods and Technology INTRODUCTION: The application of digital monitoring biomarkers in health, wellness and disease management is reviewed. Harnessing the near limitless capacity of these approaches in the managed healthcare continuum will benefit from a systems-based architecture which presents data quality, quantity, and ease of capture within a decision-making dashboard. METHODS: A framework was developed which stratifies key components and advances the concept of contextualized biomarkers. The framework codifies how direct, indirect, composite, and contextualized composite data can drive innovation for the application of digital biomarkers in healthcare. RESULTS: The de novo framework implies consideration of physiological, behavioral, and environmental factors in the context of biomarker capture and analysis. Application in disease and wellness is highlighted, and incorporation in clinical feedback loops and closed-loop systems is illustrated. CONCLUSIONS: The study of contextualized biomarkers has the potential to offer rich and insightful data for clinical decision making. Moreover, advancement of the field will benefit from innovation at the intersection of medicine, engineering, and science. Technological developments in this dynamic field will thus fuel its logical evolution guided by inputs from patients, physicians, healthcare providers, end-payors, actuarists, medical device manufacturers, and drug companies. Cambridge University Press 2018-04-23 /pmc/articles/PMC5916505/ /pubmed/29707260 http://dx.doi.org/10.1017/cts.2018.4 Text en © The Association for Clinical and Translational Science 2018 http://creativecommons.org/licenses/by/4.0/ This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Methods and Technology Kovalchick, Christopher Sirkar, Rhea Regele, Oliver B. Kourtis, Lampros C. Schiller, Marie Wolpert, Howard Alden, Rhett G. Jones, Graham B. Wright, Justin M. Can composite digital monitoring biomarkers come of age? A framework for utilization |
title | Can composite digital monitoring biomarkers come of age? A framework for utilization |
title_full | Can composite digital monitoring biomarkers come of age? A framework for utilization |
title_fullStr | Can composite digital monitoring biomarkers come of age? A framework for utilization |
title_full_unstemmed | Can composite digital monitoring biomarkers come of age? A framework for utilization |
title_short | Can composite digital monitoring biomarkers come of age? A framework for utilization |
title_sort | can composite digital monitoring biomarkers come of age? a framework for utilization |
topic | Research Methods and Technology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5916505/ https://www.ncbi.nlm.nih.gov/pubmed/29707260 http://dx.doi.org/10.1017/cts.2018.4 |
work_keys_str_mv | AT kovalchickchristopher cancompositedigitalmonitoringbiomarkerscomeofageaframeworkforutilization AT sirkarrhea cancompositedigitalmonitoringbiomarkerscomeofageaframeworkforutilization AT regeleoliverb cancompositedigitalmonitoringbiomarkerscomeofageaframeworkforutilization AT kourtislamprosc cancompositedigitalmonitoringbiomarkerscomeofageaframeworkforutilization AT schillermarie cancompositedigitalmonitoringbiomarkerscomeofageaframeworkforutilization AT wolperthoward cancompositedigitalmonitoringbiomarkerscomeofageaframeworkforutilization AT aldenrhettg cancompositedigitalmonitoringbiomarkerscomeofageaframeworkforutilization AT jonesgrahamb cancompositedigitalmonitoringbiomarkerscomeofageaframeworkforutilization AT wrightjustinm cancompositedigitalmonitoringbiomarkerscomeofageaframeworkforutilization |